Key result
Amphetamine use was associated with the development of pulmonary arterial hypertension in a 43-year-old male with nephrotic syndrome.
Why the study?
Diagnosing pulmonary arterial hypertension in nephrotic syndrome is challenging due to overlapping signs and symptoms.
Population
A 43-year-old male with nephrotic syndrome and PAH secondary to amphetamine
Design
Case report
Authors
Loading...
Alerts clinicians to possible PAH in amphetamine users with nephrotic syndrome; leaves open causality and generalizability.
Case Report (n=1)
Highlights the risk of pulmonary arterial hypertension associated with amphetamine use, particularly in patients with underlying nephrotic syndrome.
Khan et al. (2023) conducted a case report in Pulmonary arterial hypertension and nephrotic syndrome (n=1). Amphetamine was evaluated. Amphetamine use was associated with the development of pulmonary arterial hypertension in a 43-year-old male with nephrotic syndrome.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: